EUVIMEDEUVIMED entdecken
Crossref

Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer

Wei Zhang iD, Long Ngo, Simon Chang-Hao Tsao, Dingbin Liu iD, Yuling Wang iD

ACS Applied Materials & Interfaces · 05.04.2023 · 15 (13) · 16420-16433

DOI: 10.1021/acsami.2c22749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 24.03.2023. Verfasst von Wei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), Macquarie University, Sydney, NSW 2109, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Royal Australasian College of Surgeons, Ministry of Science and Technology of the People's Republic of China, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsExtracellular VesiclesHumansFemaleLiposomesDrug Delivery SystemsGemcitabine

Stichwörter der Autor:innen

breast cancerdrug delivery systemelectroporationextracellular vesicleshybrid particlesliposomesmiRNA inhibitor

Substanzen

LiposomesGemcitabine

Autor:innen und Institutionen

  • ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), Macquarie University, Sydney, NSW 2109, Australia.
  • School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, Australia.
  • Department of Surgery, St Vincent's Hospital, University of Melbourne, Melbourne, VIC 3010, Australia.
  • State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, C…

ORCID-Profile: Wei Zhang, Dingbin Liu, Yuling Wang

Förderung

  • Royal Australasian College of Surgeons
  • Ministry of Science and Technology of the People's Republic of China
  • Australian Research Council
  • National Natural Science Foundation of China
  • James and Diana Ramsay Foundation
  • Foundation of Surgery

Zitieren

APA

Zhang, W., Ngo, L., Tsao, S. C., Liu, D., & Wang, Y. (2023). Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer. ACS Applied Materials & Interfaces, 15(13), 16420-16433. https://doi.org/10.1021/acsami.2c22749

Vancouver

Zhang W, Ngo L, Tsao SC, Liu D, Wang Y. Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer. ACS Applied Materials & Interfaces. 2023;15(13):16420-16433. doi:10.1021/acsami.2c22749

BibTeX
@article{Zhang2023,
  author = {Zhang, Wei and Ngo, Long and Tsao, Simon Chang-Hao and Liu, Dingbin and Wang, Yuling},
  title = {Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  volume = {15},
  number = {13},
  pages = {16420--16433},
  doi = {10.1021/acsami.2c22749}
}
Kostenlos starten →